Case Study:
Integrated performance analysis with AI
How AI is answering commercial teams questions immediately saving analytics team times
Many commercial teams have analytics teams supporting them to whom they send questions to. For several of our clients, the main team is not large enough to answer all of the requests and they often have teams of data scientists in India that they send the questions to. But even then, it is humans doing the analysis. The majority of requests take hours to days to calculate the answers. We did a project for one client in which they were getting almost 300 requests a week and the backlog of questions to answer was piling up. The answer – utilising a combination of NLP and ML to automatically calculate the answers in a platform in which you could put the questions in natural language as you would with a human, as well as deep dive interrogations as to why, and automatically create C-Suite ready PowerPoint slides and excels as needed – in 5-15 mins.
The Client
- Small analytics team for all products
- Internal data is not integrated (program data, flow data etc)
- Constrains efficient use of resources
The Solution
- Data-driven Artificial Intelligence to crunch data and speed up time to answer questions to allow the human team to focus on the strategic insights
The Outcome
- After data is wrangled and combined, can be set up to pipe data into the platform. Then it takes 5-15 mins to answer questions and have visualisations of the answers as well.
- Game. Changed!
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.

Are LLMs Already On Their Way to Being Obsolete?
The AI world is racing forward with near-religious confidence in large language models, yet one of the field’s most influential pioneers is already drafting their

CRO 2.0: Transforming Tomorrow’s Clinical Research Process with Artificial Intelligence
The clinical trial ecosystem – a $90 billion engine driving medical innovation is struggling under the burden of its own complexity. Despite significant advancements in

The Hidden Cost of Having No AI Strategy (Spoiler: It’s Not What You Think)
In the past few years, almost 70% of biopharma companies have initiated AI initiatives. Yet, fewer than 20% report a cohesive AI strategy at the